AbbVie reports positive Phase II ovarian cancer trial data
AbbVie has reported positive topline data from the Phase II PICCOLO clinical trial of mirvetuximab soravtansine (ELAHERE) monotherapy in heavily pre-treated high folate receptor-alpha (FRα)-positive platinum-sensitive ovarian cancer (PSOC) patients. The …